Our facility focusses on the development and production of monoclonal and polyclonal antibodies.
Antibodies are a fundamental component of successful research and clinical translation. The staff in the WEHI Antibody Facility are experts in antibody development and production, providing fully customised, fast and reliable antibody services.
The Antibody Facility also provides services to external academic researchers, pharmaceutical and biotechnology companies.